Skip to main content
. 2019 Sep 8;2019:2782417. doi: 10.1155/2019/2782417

Figure 6.

Figure 6

TRPV1-mediated CCI-induced neuropathic pain via regulation by MZF1 in DRGs. (a, b) DRG microinjection of rAAV5-MZF1 increased MZF1 and TRPV1 mRNA levels (a) and protein expression (b). ∗P < 0.05 and ∗∗P < 0.01 vs. the rAAV5-EGFP group (Student's t-test). (c, d) DRG microinjection of MZF1 siRNA abolished CCI-induced increases in MZF1 and TRVP1 mRNA levels (c) and protein expression (d). ∗P < 0.05 and ∗∗P < 0.01 vs. the sham+vehicle group and ##P < 0.01 vs. the CCI+vehicle group (one-way ANOVA).